跳至主要内容
临床试验/NCT02653859
NCT02653859Unknown不适用

Evaluate the Auxiliary Diagnostic Value of Circulating Tumor Cells(CTC) in Benign and Malignant Lung Nodules

GenoSaber0 个研究点目标入组 50 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
50
主要终点
The number of circulating tumor cells will be detected in baseline by Immunomagnetic negative screening and targeted polymerase chain reaction(PCR) method.

研究概览

简要总结

By testing the CTC number of new solitary pulmonary nodule patient, evaluating the correlation of CTC number and benign and malignant lung nodules auxiliary diagnosis, the correlation of CTC number and the size of lung nodules of the malignant patients, the correlation between the CTC number and subtypes of malignant lung nodules patients.The CTC and tumor markers will be detected before the patient received treatment. Tumor markers include Pro-GRP, NSE, CEA, CYFRA211, SCC.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • New Solitary Pulmonary Nodule patients
  • first visit patient
  • Heart, liver and kidney function is normal.
  • 18-80 years old.
  • Ability to understand and the willingness to sign a written informed consent document.

排除标准

  • Blood collection time is not in the scheduled time.
  • The plasma sample hemolysis or condensation.
  • Whole blood samples less than 3 ml.
  • poor compliance

结局指标

主要结局

The number of circulating tumor cells will be detected in baseline by Immunomagnetic negative screening and targeted polymerase chain reaction(PCR) method.

时间窗: 1 months

The 3 mL of blood will be taked with each patient for CTCs detection.

次要结局

  • The concentration of the tumor marker of pro gastrin releasing peptide(Pro-GRP) will be detected in baseline by Electrochemical luminescence.(1 months)
  • The concentration of the tumor marker of carcinoembryonic antigen(CEA) will be detected in baseline by Electrochemical luminescence.(1 months)
  • The concentration of the tumor marker of cytokeratin 19 fragments(CYFRA211) will be detected in baseline by Electrochemical luminescence.(1 months)
  • The concentration of the tumor marker of neurone specific enolase(NSE) will be detected in baseline by Electrochemical luminescence.(1 months)
  • The concentration of the tumor marker of squamous cell carcinoma antigen(SCC) will be detected in baseline by Electrochemical luminescence.(1 months)

研究者

发起方
GenoSaber
申办方类型
Industry
责任方
Sponsor

相似试验